Szabolcs Ottó
About
In The Last Decade
Szabolcs Ottó
24 papers receiving 361 citations
Peers
Comparison fields: 5 of 61
- Oncology 209
- Pathology and Forensic Medicine 162
- Cancer Research 99
- Molecular Biology 91
- Pulmonary and Respiratory Medicine 60
Countries citing papers authored by Szabolcs Ottó
This map shows the geographic impact of Szabolcs Ottó's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Szabolcs Ottó with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Szabolcs Ottó more than expected).
Fields of papers citing papers by Szabolcs Ottó
This network shows the impact of papers produced by Szabolcs Ottó. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Szabolcs Ottó. The network helps show where Szabolcs Ottó may publish in the future.
Co-authorship network of co-authors of Szabolcs Ottó
This figure shows the co-authorship network connecting the top 25 collaborators of Szabolcs Ottó. A scholar is included among the top collaborators of Szabolcs Ottó based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Szabolcs Ottó. Szabolcs Ottó is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 20 | |
| 2 | A rákmorbiditás és -mortalitás jelenlegi helyzete a Nemzeti Rákregiszter tükrében | The current situation of cancer morbidity and mortality in the light of the National Cancer Registry, Hungary | 16 |
| 3 | 3 | |
| 4 | 39 | |
| 5 | 117 | |
| 6 | 10 | |
| 7 | 9 | |
| 8 | [Trends in cancer mortality and morbidity in Hungarian and international statistics. Characteristics and potential outcome of public health screening programs]. | 21 |
| 9 | [Role of S100B protein in neoplasms and other diseases]. | 5 |
| 10 | 8 | |
| 11 | [Laboratory markers of melanoma progression]. | 5 |
| 12 | 34 | |
| 13 | [Tumour markers in human breast cyst fluid in gross cystic breast disease (GCBD)] | 1 |
| 14 | 16 | |
| 15 | 2 | |
| 16 | 6 | |
| 17 | 4 | |
| 18 | 11 | |
| 19 | 6 | |
| 20 | 4 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.